Clinical trials
Nephrolithiasis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| University of British Columbia | 2 |
| Adva-Tec | 1 |
| Children's Hospital of Philadelphia | 1 |
| Clinical Urology and Epidemiology Working Group | 1 |
| Mayo Clinic | 1 |
| Nova Scotia Health Authority | 1 |
| Sault Area Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephrolithiasis | 21 |
| Kidney Calculi | 11 |
| Urolithiasis | 3 |
| Calcium Metabolism Disorders | 2 |
| Hypercalciuria | 2 |
| Hypocalcemia | 2 |
| Hypoparathyroidism | 2 |
| Metabolic Diseases | 2 |
| Muscular Diseases | 2 |
| Musculoskeletal Abnormalities | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.